Polio is a crippling disease caused by a virus that attacks the nervous system. Not only will it deprive you of mobility, but it will also significantly shorten your life and change your quality of living. There remains no cure for this illness, but there are now many ways to prevent and manage it. The same is the case for Alzheimer’s, cancer, and epilepsy.
Medical conditions that do not have known cures are best managed with the right medication. A clinical trial is a three-step process that determines the effectiveness of a trial drug. The phase 1 clinical trial is where it all starts. Below are some of the most common questions asked which can help you know more about the process.
What is the purpose of phase 1 clinical trials?
The main goal of these is to assess the safety of a medication or device. Phase 1 has a relatively small number of participants, ranging from 20 to 100. Aside from assessing the safety of a drug, medical researchers also evaluate its effects, particularly how it is absorbed, metabolized, and excreted by the human body.
Who are qualified to participate?
Qualifications depend on the medication being studied. In some cases, phase 1 would require a healthy test subject. In some cases, people who have advanced stage cancer or other medical conditions are invited to participate. Participants who volunteer are all compensated.
What can one expect from the trial process?
Participants will be put in a controlled environment, which means their medication, food intake, and lifestyle may be altered based on the standards needed for the trial to take place. Blood tests are also done to monitor how the body responds to the medication. In most cases, participants and medical practitioners alike will not be informed about the presence of placebo (if there are any) to get more accurate results.
Phase 1 is very important, as it determines whether a drug can undergo the phase 2 process. Thanks to these lengthy processes and volunteers, modern medicine can continue to evolve and save more people’s lives.